1 unchanged sentence
and Use of Proceeds.
−Removed: During the three months ended
−Removed: June 30, 2025, we issued 10,000 shares of common stock to an advisor in exchange for services.
−Removed: The shares of common stock were issued in
−Removed: reliance upon an exemption from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act.
+Added: During the three months ended September 30, 2025, we issued 120,000
+Added: shares of common stock to an advisor in exchange for services.
+Added: The shares of common stock were issued in reliance upon an exemption
+Added: from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act.
The following exhibits are
filed with this Quarterly Report on Form 10-Q:
+Added: At Market Issuance Sales Agreement, dated August 8, 2025, between OS Therapies Incorporated and B.
+Added: Riley Securities, Inc.
+Added: and JonesTrading Institutional Services LLC (incorporated by reference to Exhibit 1.2 to the Registration Statement on Form S-3 filed with the SEC on August 8, 2025).
+Added: Amendment No.
+Added: 1 to the Amended and Restated Bylaws of OS Therapies Incorporated (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on August 15, 2025).
Form of Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed with the SEC on June 24, 2025).
−Removed: Form of Inducement Offer Letter (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on June 24, 2025).
+Added: Form of Senior Indenture between the Registrant and one or more trustees to be named (incorporated by reference to Exhibit 4.13 to the Registration Statement on Form S-3 filed with the SEC on August 8, 2025).
+Added: Form of Subordinated Debt Indenture between the Registrant and one or more trustees to be named (incorporated by reference to Exhibit 4.14 to the Registration Statement on Form S-3 filed with the SEC on August 8, 2025).
+Added: Form of Inducement Offer Letter (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on September 2, 2025).
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
2 unchanged sentences
§ 1350 As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: The following financial statements from the Company’s Quarterly
−Removed: Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline XBRL:
−Removed: (i) Balance Sheets as of June 30, 2025 and December
−Removed: 31, 2024 (unaudited);
−Removed: (ii) Statements of Operations for the three and six months ended June 30, 2025 and 2024 (unaudited);
−Removed: (iii) Statements
−Removed: of Stockholders’ Equity (Deficit) for the three and six months ended June 30, 2025 and 2024 (unaudited);
−Removed: (iv) Statements of Cash
−Removed: Flows for the six months ended June 30, 2025 and 2024 (unaudited);
−Removed: and (v) Notes to the Financial Statements (unaudited).
−Removed: The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline XBRL (included as Exhibit 101).
+Added: The following consolidated financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline XBRL:
+Added: (i) Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 (unaudited);
+Added: (ii) Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024 (unaudited);
+Added: (iii) Consolidated Statements of Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2025 and 2024 (unaudited);
+Added: (iv) Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 (unaudited);
+Added: and (v) Notes to the Consolidated Financial Statements (unaudited).
+Added: The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline XBRL (included as Exhibit 101).
* Furnished herewith.
3 unchanged sentences
OS THERAPIES INCORPORATED
−Removed: August 18, 2025
+Added: November 14, 2025
/s/ Paul Romness
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 18, 2025
+Added: November 14, 2025
/s/ Christopher Acevedo
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.